NCT03494257View on ClinicalTrials.gov

Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 4, 2017

Primary Completion Date

March 20, 2018

Study Completion Date

April 6, 2018

Conditions

CataractIntraocular Pressure

Interventions

DRUG

Brinzolamide-Brimonidine fixed combination

Simbrinza 0.2%-1% Ophthalmic Suspension

Trial Locations (1)

26504

University Hospital of Patras, Pátrai

All Listed Sponsors

lead

University Hospital of Patras

OTHER

NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification | Biotech Hunter | Biotech Hunter